[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
May 26, 2004

Rise in Drug-Resistant Gonorrhea Cases

JAMA. 2004;291(20):2420. doi:10.1001/jama.291.20.2420

The Centers for Disease Control and Prevention (CDC) is recommending that fluoroquinolones—ciprofloxacin, ofloxacin, and levofloxacin—no longer be used as first-line treatment for gonorrhea in gay and bisexual men. The recommendation was made after preliminary data from a CDC study showed that drug-resistant gonorrhea cases increased significantly in the United States in 2003, particularly among men who have sex with men.

First Page Preview View Large
First page PDF preview
First page PDF preview